Epaned FDA Approval History
Last updated by Judith Stewart, BPharm on July 9, 2019.
FDA Approved: Yes (First approved August 13, 2013)
Brand name: Epaned
Generic name: enalapril maleate
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals, Inc.
Treatment for: High Blood Pressure, Heart Failure, Left Ventricular Dysfunction
Epaned (enalapril maleate) is an angiotensin-converting enzyme inhibitor indicated for the treatment of hypertension in adults and children older than one month, symptomatic heart failure, and asymptomatic left ventricular dysfunction.
Development timeline for Epaned
|Jan 10, 2017||Approval Epaned (enalapril maleate) Oral Solution is Now Available|
|Sep 8, 2014||Approval FDA Approves Two New Indications for Epaned, the First and Only Enalapril Powder for Oral Solution|
|Aug 14, 2013||Approval FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.